FDANovember 14, 2024drug

Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

What to do

FDA enforcement status: Ongoing

Brands named

amerisource health servicesamerisourceamerisource health

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →